Body dysmorphic disorder is a psychiatric condition: a persistent preoccupation with a defect in appearance that others do not see, or barely see, with repetitive behaviours and a distress that weighs on daily life. You meet it in an aesthetic practice, and according to the literature it often goes unrecognised.
Studies describe screening questionnaires. A questionnaire flags who may have the disorder, it does not diagnose it: confirmation is down to a mental health specialist. In the record, write that screening was done, with which instrument, the result as data, and what you decided. The program does not classify anyone and does not decide for you.
What it is and why you meet it
The StatPearls entry defines it with the criteria of the DSM-5-TR diagnostic manual: a preoccupation with one or more defects in appearance that are not seen or barely seen, repetitive behaviours (checking the mirror, camouflaging the defect, touching the skin, mentally comparing oneself with others), a distress or impairment in an important area of life, and the fact that an eating disorder does not better explain the picture (StatPearls, Body Dysmorphic Disorder (opens in a new tab)).
The same entry estimates global prevalence at between 2 and 3 per cent, and around 13 per cent in cosmetic surgery clinics. A survey of 412 people awaiting an aesthetic treatment in a clinic recalls, for the general population, 1.9 per cent and, for those seeking aesthetic skin treatments, about 9 per cent (Yurtsever et al., 2022 (opens in a new tab)). These are figures from different studies, with different instruments: they are not an estimate for your practice, they only say that someone seeking an aesthetic treatment is more likely than others to have this condition.
Two points from StatPearls have a practical consequence for whoever writes the record. The first: patients often do not report the symptoms of their own accord, and the entry recommends asking about them directly. The second: among the listed clues are a history of unsuccessful aesthetic procedures and the idea that others are mocking them. A clue is not a diagnosis: it is a fact to note down.
Screening instruments: what the studies say
A 2011 systematic review looked for the screening instruments used in the aesthetic field and found six. Only two had been validated for cosmetic skin treatments: the BDDQ-DV, that is the version of the BDDQ questionnaire designed for that setting, and the DCQ, the questionnaire on preoccupation with appearance. Outside that setting, no instrument had been validated. The authors write that the scarcity of validated instruments contrasts with the high estimated prevalence, and that for the BDDQ-DV there was no evidence of an influence on the subjective outcome after treatment (Picavet et al., 2011 (opens in a new tab)).
The BDDQ is short and self-administered. The Saudi study describes it as drawn from the DSM diagnostic criteria, developed among psychiatric patients and then also validated in facial plastic surgery and oculoplastic surgery; for aesthetic clinics the authors report a sensitivity of 100 per cent and a specificity of between 89 and 93 per cent. In the study, 19.2 per cent of the 344 participants tested positive. If you have no instrument, you can start with targeted questions about appearance: the authors suggest, for example, asking whether the patient is concerned about their appearance and how much time they spend worrying about it (PMC7841516 (opens in a new tab)).
Read one figure at a time, because the percentages change with the instrument and with the threshold. In the survey of 412 people, the prevalence of the disorder ranged from 7.28 to 11.17 per cent depending on the screening instrument used (in all, the participants had completed six questionnaires, including on body image and self-esteem) (PMC9821449 (opens in a new tab)). That is why in the record it matters to write which instrument you used, not just the result.
A rule-based automated instrument: what it says and what it does not say
A 2025 study, by a plastic surgeon with an individual practice in Buenos Aires, put the BDDQ inside a rule-based system: the patient completes an online questionnaire, a fixed algorithm combines the score with other information (age, sex, previous procedures, psychiatric medication, recent stress) and flags who is at risk. Out of 3,722 adults, 1,080 (29.02 per cent) tested positive; the positive cases were assessed before deciding whether to operate, and only 8 were operated on (Bukret, 2025 (opens in a new tab)).
What it does not say. The author himself states that it is not a validation study, that it comes from a single professional practice, that the group of 8 operated patients is too small to draw conclusions, and that the instrument does not replace psychiatric assessment but helps to recognise the case and refer it. The meaning is the same as with the BDDQ: the instrument flags, the person decides. The number of positives depends on the instrument and threshold used, and must not be read as the frequency of the disorder among your patients.
What you write in the record
The record must allow whoever reads it in two years' time to understand what was asked, what the result was and what you decided. A proposed set of fields:
| Field | What it contains |
|---|---|
| Screening performed | Yes, no, or deferred; if not performed, the reason in one line |
| Instrument | Name of the questionnaire, version and language |
| Date and who administered it | Date, and whether the patient completed it alone or with you |
| Result | The score as data, without adjectives |
| Observations | Facts observed or reported, in the patient's words, without diagnosis |
| Decision | What you decided (for example deferring the choice of treatment, or recommending an assessment by a mental health specialist) and why |
| What you told the patient | Briefly, and their response |
If you refer the patient to a colleague, note to whom, on what date, what you handed over (a letter, a referral) and what the patient replied. A patient's refusal is information like any other, and is recorded as such.
An example row, with fictitious data:
| Date | Patient | Instrument | Result | Decision |
|---|---|---|---|---|
| 12/03/2026 | Example patient B | BDDQ, version and language as stated | (score as per questionnaire) | Choice of treatment deferred; patient recommended for assessment by a mental health specialist; the patient said they would think about it |
Two clarifications. If you do not use a questionnaire, do not invent a score: write what you observed and what the patient told you, in facts. And if the patient completes a form before arriving, their answers are a statement, not a diagnosis: they remain proposals until you accept them.
What the program does, and what it does not
Fibonacci is a record system: it stores what you enter. In the Questionnaires tab of the clinical record you choose the questionnaire from the available list, complete it together with the patient or hand them the tablet, and save; below it the history with dates appears, and questions that express a measurement are recorded as measurable data (questionnaires). The tab appears only if the feature is enabled for the practice, and which questionnaires are there depends on how they are defined: they are data in the questionnaire, not lines of code.
The rest is up to you. The program does not form a diagnostic suspicion about the patient, does not say whether a screening is positive and does not propose the decision. The answers of a form completed before the visit do not enter the record until a doctor accepts them one by one, because what a patient declares becomes clinical data only when someone takes responsibility for it. And dictation never writes on its own: between the voice and the saved data there is a review and a button that you press.
For the picture of the whole visit (history, scales, photos, consent) see the article on the first visit; for the scales used in the visit, Fitzpatrick, Glogau and FACE-Q; for the questions to ask, the history. The short guide is the first visit in aesthetic medicine; for the information given to the patient, informed consent.




